Literature DB >> 7381644

Secretory IgA in the serum of infants with obstructive jaundice.

R M Goldblum, G K Powell, G Van Sickle.   

Abstract

The liver is capable of transporting IgA from the plasma to bile in several experimental animals. After bile duct ligation, SIgA and free secretory component accumulate in the serum of these animals. In the present study, SIgA was found in the serum of all infants with extrahepatic biliary obstruction, and in 75% of those with intrahepatic cholestasis, but in only one of seven age-matched infants without hepatobiliary disease. Infants with EHBO had significantly higher serum levels of secretory IgA and total IgA than in normal infants or patients with IHC. This result suggests that the human liver is involved in SIgA metabolism and that the elevated serum IgA levels in infants with liver disease are caused by bile duct obstruction or proliferation. Quantitation of SIgA in serum may help to differentiate major categories of obstructive jaundice in infancy. The concentration of SIgA in serum was indicative of the site of obstruction in 12 of 19 infants with hepatobiliary disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7381644     DOI: 10.1016/s0022-3476(80)80125-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

1.  Comparative studies on immunoglobulins, complement component (C3), albumin, and immunoglobulin A-containing circulating immune complexes in serum and bile of patients with biliary obstruction.

Authors:  G Ohshio; F Furukawa; T Manabe; T Tobe; Y Hamashima
Journal:  Dig Dis Sci       Date:  1988-05       Impact factor: 3.199

Review 2.  Mucosal defense against enteric pathogens.

Authors:  S C Sanyal
Journal:  Indian J Pediatr       Date:  1983 May-Jun       Impact factor: 1.967

3.  Serologic assay for secretory component distinguishes mechanical from hepatocellular cholestasis in humans.

Authors:  M R Versland; G Y Wu; F S Gorelick; J M Larkin
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

4.  High serum levels of secretory IgA in liver disease: possible liver origin of the circulating secretory component.

Authors:  D L Delacroix; M Reynaert; S Pauwels; A P Geubel; J P Vaerman
Journal:  Dig Dis Sci       Date:  1982-04       Impact factor: 3.199

5.  Dual role of the liver in regulating circulating polymeric IgA in man: studies on patients with liver disease.

Authors:  K G Chandy; S G Hübscher; E Elias; J Berg; M Khan; D Burnett
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

6.  A search for an enriched source of polymeric IgA in human thoracic duct lymph, portal vein blood and aortic blood.

Authors:  W R Brown; P D Smith; E Lee; R T McCalmon; H Nagura
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

7.  Enhanced immunoglobulin, A release from human colostral cells during phagocytosis.

Authors:  E A Weaver; R M Goldblum; C P Davis; A S Goldman
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.